Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial

It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children. This present study was designed to determine the effects of different doses of intravenous dexmedetomidine...

Full description

Saved in:
Bibliographic Details
Published in:BMC anesthesiology 2018-01, Vol.18 (1), p.9-9, Article 9
Main Authors: Di, Meiqin, Yang, Zhuqing, Qi, Dansi, Lai, Hongyan, Wu, Junzheng, Liu, Huacheng, Ye, Xuefei, ShangGuan, Wangning, Lian, Qingquan, Li, Jun
Format: Article
Language:English
Subjects:
Dexmedetomidine
Dosage and administration
Extubation
Intubation
Methods
Minimum alveolar concentration
Pediatric
Pediatric anesthesia
Sevoflurane
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63
cites cdi_FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63
container_end_page 9
container_issue 1
container_start_page 9
container_title BMC anesthesiology
container_volume 18
creator Di, Meiqin
Yang, Zhuqing
Qi, Dansi
Lai, Hongyan
Wu, Junzheng
Liu, Huacheng
Ye, Xuefei
ShangGuan, Wangning
Lian, Qingquan
Li, Jun
description It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children. This present study was designed to determine the effects of different doses of intravenous dexmedetomidine pre-medication on minimum alveolar concentration of sevoflurane for smooth tracheal extubation (MAC ) in anesthetized children. A total of seventy-five pediatric patients, aged 3-7 years, ASA physical status I and II, and undergoing tonsillectomy were randomized to receive intravenous saline (Group D ), dexmedetomidine 1 μg∙kg (Group D ), or dexmedetomidine 2 μg∙kg (Group D ) approximately 10 min before anesthesia start. Sevoflurane was used for anesthesia induction and anesthesia maintenance. At the end of surgery, the initial concentration of sevoflurane for smooth tracheal extubation was determined according to the modified Dixon's "up-and-down" method. The starting sevoflurane for the first patient was 1.5% in Group D , 1.0% in Group D , and 0.8% in Group D , with subsequent 0.1% up or down in next patient based on whether smooth extubation had been achieved or not in current patient. The endotreacheal tube was removed after the predetermined concentration had been maintained constant for ten minutes. All responses ("smooth" or "not smooth") to tracheal extubation and respiratory complications were assessed. MAC values of sevoflurane in Group D (0.51 ± 0.13%) was significantly lower than in Group D (0.83 ± 0.10%; P 
doi_str_mv 10.1186/s12871-018-0469-9
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7d16b398f957435dbc60dab8ab2875ea</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A523594097</galeid><doaj_id>oai_doaj_org_article_7d16b398f957435dbc60dab8ab2875ea</doaj_id><sourcerecordid>A523594097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63</originalsourceid><addsrcrecordid>eNptUsFu1DAUjBCIlsIHcEGWuHBJseM4jjkgVVULK1XiAmfLsV92XTnx1k5WLZ_Hl_F2U6quhHywNZ4ZP897RfGe0XPG2uZzZlUrWUlZW9K6UaV6UZyyGpGqEvzls_NJ8SbnW0qZbCl_XZxUite84tVp8Wc1TsnsYIxzJg7uB3AwxcE7PwLZJigR8NZMPo4kgZstZDJtAM93s0eADH70wzwQE3YQg0nExtHC3vSgiT3JsIt9mJNBxz4mkocYpw1Bht2ACQTup7lb2H4kyMr4wOR_o7nd-OASjF-IIah3WNgBDvioRemUvAlvi1e9CRnePe5nxa_rq5-X38ubH99Wlxc3pRW8msqm6ZxqWdeCtMo6amojKbeiFn3FRdWIxioQVHFKTSdlBbKvuTF1ZQ11yjX8rFgtvi6aW71NfjDpQUfj9QGIaa1NmrwNoKVjTcdV2yshay5cZxvqTNeaDhsmwKDX18VrO3eY8BJYODI9vhn9Rq_jTgspOatrNPj0aJDi3YyR6cFnCyFgfthKzVSrBC7KkPpxoa4NlubHPu6j39P1hcCvq5oqiazz_7BwORg89hR6j_iRgC0Cm2LOCfqn6hnV-_HUy3hqHE-9H0-tUPPh-befFP_mkf8F29zmqw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989595901</pqid></control><display><type>article</type><title>Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><creator>Di, Meiqin ; Yang, Zhuqing ; Qi, Dansi ; Lai, Hongyan ; Wu, Junzheng ; Liu, Huacheng ; Ye, Xuefei ; ShangGuan, Wangning ; Lian, Qingquan ; Li, Jun</creator><creatorcontrib>Di, Meiqin ; Yang, Zhuqing ; Qi, Dansi ; Lai, Hongyan ; Wu, Junzheng ; Liu, Huacheng ; Ye, Xuefei ; ShangGuan, Wangning ; Lian, Qingquan ; Li, Jun</creatorcontrib><description>It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children. This present study was designed to determine the effects of different doses of intravenous dexmedetomidine pre-medication on minimum alveolar concentration of sevoflurane for smooth tracheal extubation (MAC ) in anesthetized children. A total of seventy-five pediatric patients, aged 3-7 years, ASA physical status I and II, and undergoing tonsillectomy were randomized to receive intravenous saline (Group D ), dexmedetomidine 1 μg∙kg (Group D ), or dexmedetomidine 2 μg∙kg (Group D ) approximately 10 min before anesthesia start. Sevoflurane was used for anesthesia induction and anesthesia maintenance. At the end of surgery, the initial concentration of sevoflurane for smooth tracheal extubation was determined according to the modified Dixon's "up-and-down" method. The starting sevoflurane for the first patient was 1.5% in Group D , 1.0% in Group D , and 0.8% in Group D , with subsequent 0.1% up or down in next patient based on whether smooth extubation had been achieved or not in current patient. The endotreacheal tube was removed after the predetermined concentration had been maintained constant for ten minutes. All responses ("smooth" or "not smooth") to tracheal extubation and respiratory complications were assessed. MAC values of sevoflurane in Group D (0.51 ± 0.13%) was significantly lower than in Group D (0.83 ± 0.10%; P &lt; 0.001), the latter being significantly lower than in Group D (1.40 ± 0.12%; P &lt; 0.001). EC values of sevoflurane were 0.83%, 1.07%, and 1.73% in Group D , Group D , and Group D , respectively. No patient in the current study had laryngospasm. Dexmedetomidine decreased the required MAC values of sevoflurane to achieve smooth extubation in a dose-dependent manner. Intravenous dexmedetomidine 1 μg∙kg and 2 μg∙kg pre-medication decreased MAC by 41% and 64%, respectively. Chinese Clinical Trial Registry (ChiCTR): ChiCTR-IOD-17011601 , date of registration: 09 Jun 2017, retrospectively registered.</description><identifier>ISSN: 1471-2253</identifier><identifier>EISSN: 1471-2253</identifier><identifier>DOI: 10.1186/s12871-018-0469-9</identifier><identifier>PMID: 29343232</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Dexmedetomidine ; Dosage and administration ; Extubation ; Intubation ; Methods ; Minimum alveolar concentration ; Pediatric ; Pediatric anesthesia ; Sevoflurane</subject><ispartof>BMC anesthesiology, 2018-01, Vol.18 (1), p.9-9, Article 9</ispartof><rights>COPYRIGHT 2018 BioMed Central Ltd.</rights><rights>The Author(s). 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63</citedby><cites>FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63</cites><orcidid>0000-0002-9569-2454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773144/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773144/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29343232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Di, Meiqin</creatorcontrib><creatorcontrib>Yang, Zhuqing</creatorcontrib><creatorcontrib>Qi, Dansi</creatorcontrib><creatorcontrib>Lai, Hongyan</creatorcontrib><creatorcontrib>Wu, Junzheng</creatorcontrib><creatorcontrib>Liu, Huacheng</creatorcontrib><creatorcontrib>Ye, Xuefei</creatorcontrib><creatorcontrib>ShangGuan, Wangning</creatorcontrib><creatorcontrib>Lian, Qingquan</creatorcontrib><creatorcontrib>Li, Jun</creatorcontrib><title>Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial</title><title>BMC anesthesiology</title><addtitle>BMC Anesthesiol</addtitle><description>It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children. This present study was designed to determine the effects of different doses of intravenous dexmedetomidine pre-medication on minimum alveolar concentration of sevoflurane for smooth tracheal extubation (MAC ) in anesthetized children. A total of seventy-five pediatric patients, aged 3-7 years, ASA physical status I and II, and undergoing tonsillectomy were randomized to receive intravenous saline (Group D ), dexmedetomidine 1 μg∙kg (Group D ), or dexmedetomidine 2 μg∙kg (Group D ) approximately 10 min before anesthesia start. Sevoflurane was used for anesthesia induction and anesthesia maintenance. At the end of surgery, the initial concentration of sevoflurane for smooth tracheal extubation was determined according to the modified Dixon's "up-and-down" method. The starting sevoflurane for the first patient was 1.5% in Group D , 1.0% in Group D , and 0.8% in Group D , with subsequent 0.1% up or down in next patient based on whether smooth extubation had been achieved or not in current patient. The endotreacheal tube was removed after the predetermined concentration had been maintained constant for ten minutes. All responses ("smooth" or "not smooth") to tracheal extubation and respiratory complications were assessed. MAC values of sevoflurane in Group D (0.51 ± 0.13%) was significantly lower than in Group D (0.83 ± 0.10%; P &lt; 0.001), the latter being significantly lower than in Group D (1.40 ± 0.12%; P &lt; 0.001). EC values of sevoflurane were 0.83%, 1.07%, and 1.73% in Group D , Group D , and Group D , respectively. No patient in the current study had laryngospasm. Dexmedetomidine decreased the required MAC values of sevoflurane to achieve smooth extubation in a dose-dependent manner. Intravenous dexmedetomidine 1 μg∙kg and 2 μg∙kg pre-medication decreased MAC by 41% and 64%, respectively. Chinese Clinical Trial Registry (ChiCTR): ChiCTR-IOD-17011601 , date of registration: 09 Jun 2017, retrospectively registered.</description><subject>Dexmedetomidine</subject><subject>Dosage and administration</subject><subject>Extubation</subject><subject>Intubation</subject><subject>Methods</subject><subject>Minimum alveolar concentration</subject><subject>Pediatric</subject><subject>Pediatric anesthesia</subject><subject>Sevoflurane</subject><issn>1471-2253</issn><issn>1471-2253</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUsFu1DAUjBCIlsIHcEGWuHBJseM4jjkgVVULK1XiAmfLsV92XTnx1k5WLZ_Hl_F2U6quhHywNZ4ZP897RfGe0XPG2uZzZlUrWUlZW9K6UaV6UZyyGpGqEvzls_NJ8SbnW0qZbCl_XZxUite84tVp8Wc1TsnsYIxzJg7uB3AwxcE7PwLZJigR8NZMPo4kgZstZDJtAM93s0eADH70wzwQE3YQg0nExtHC3vSgiT3JsIt9mJNBxz4mkocYpw1Bht2ACQTup7lb2H4kyMr4wOR_o7nd-OASjF-IIah3WNgBDvioRemUvAlvi1e9CRnePe5nxa_rq5-X38ubH99Wlxc3pRW8msqm6ZxqWdeCtMo6amojKbeiFn3FRdWIxioQVHFKTSdlBbKvuTF1ZQ11yjX8rFgtvi6aW71NfjDpQUfj9QGIaa1NmrwNoKVjTcdV2yshay5cZxvqTNeaDhsmwKDX18VrO3eY8BJYODI9vhn9Rq_jTgspOatrNPj0aJDi3YyR6cFnCyFgfthKzVSrBC7KkPpxoa4NlubHPu6j39P1hcCvq5oqiazz_7BwORg89hR6j_iRgC0Cm2LOCfqn6hnV-_HUy3hqHE-9H0-tUPPh-befFP_mkf8F29zmqw</recordid><startdate>20180117</startdate><enddate>20180117</enddate><creator>Di, Meiqin</creator><creator>Yang, Zhuqing</creator><creator>Qi, Dansi</creator><creator>Lai, Hongyan</creator><creator>Wu, Junzheng</creator><creator>Liu, Huacheng</creator><creator>Ye, Xuefei</creator><creator>ShangGuan, Wangning</creator><creator>Lian, Qingquan</creator><creator>Li, Jun</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9569-2454</orcidid></search><sort><creationdate>20180117</creationdate><title>Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial</title><author>Di, Meiqin ; Yang, Zhuqing ; Qi, Dansi ; Lai, Hongyan ; Wu, Junzheng ; Liu, Huacheng ; Ye, Xuefei ; ShangGuan, Wangning ; Lian, Qingquan ; Li, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Dexmedetomidine</topic><topic>Dosage and administration</topic><topic>Extubation</topic><topic>Intubation</topic><topic>Methods</topic><topic>Minimum alveolar concentration</topic><topic>Pediatric</topic><topic>Pediatric anesthesia</topic><topic>Sevoflurane</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di, Meiqin</creatorcontrib><creatorcontrib>Yang, Zhuqing</creatorcontrib><creatorcontrib>Qi, Dansi</creatorcontrib><creatorcontrib>Lai, Hongyan</creatorcontrib><creatorcontrib>Wu, Junzheng</creatorcontrib><creatorcontrib>Liu, Huacheng</creatorcontrib><creatorcontrib>Ye, Xuefei</creatorcontrib><creatorcontrib>ShangGuan, Wangning</creatorcontrib><creatorcontrib>Lian, Qingquan</creatorcontrib><creatorcontrib>Li, Jun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC anesthesiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di, Meiqin</au><au>Yang, Zhuqing</au><au>Qi, Dansi</au><au>Lai, Hongyan</au><au>Wu, Junzheng</au><au>Liu, Huacheng</au><au>Ye, Xuefei</au><au>ShangGuan, Wangning</au><au>Lian, Qingquan</au><au>Li, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial</atitle><jtitle>BMC anesthesiology</jtitle><addtitle>BMC Anesthesiol</addtitle><date>2018-01-17</date><risdate>2018</risdate><volume>18</volume><issue>1</issue><spage>9</spage><epage>9</epage><pages>9-9</pages><artnum>9</artnum><issn>1471-2253</issn><eissn>1471-2253</eissn><abstract>It has been known that Dexmedetomidine pre-medication enhances the effects of volatile anesthetics, reduces the need of sevoflurane, and facilitates smooth extubation in anesthetized children. This present study was designed to determine the effects of different doses of intravenous dexmedetomidine pre-medication on minimum alveolar concentration of sevoflurane for smooth tracheal extubation (MAC ) in anesthetized children. A total of seventy-five pediatric patients, aged 3-7 years, ASA physical status I and II, and undergoing tonsillectomy were randomized to receive intravenous saline (Group D ), dexmedetomidine 1 μg∙kg (Group D ), or dexmedetomidine 2 μg∙kg (Group D ) approximately 10 min before anesthesia start. Sevoflurane was used for anesthesia induction and anesthesia maintenance. At the end of surgery, the initial concentration of sevoflurane for smooth tracheal extubation was determined according to the modified Dixon's "up-and-down" method. The starting sevoflurane for the first patient was 1.5% in Group D , 1.0% in Group D , and 0.8% in Group D , with subsequent 0.1% up or down in next patient based on whether smooth extubation had been achieved or not in current patient. The endotreacheal tube was removed after the predetermined concentration had been maintained constant for ten minutes. All responses ("smooth" or "not smooth") to tracheal extubation and respiratory complications were assessed. MAC values of sevoflurane in Group D (0.51 ± 0.13%) was significantly lower than in Group D (0.83 ± 0.10%; P &lt; 0.001), the latter being significantly lower than in Group D (1.40 ± 0.12%; P &lt; 0.001). EC values of sevoflurane were 0.83%, 1.07%, and 1.73% in Group D , Group D , and Group D , respectively. No patient in the current study had laryngospasm. Dexmedetomidine decreased the required MAC values of sevoflurane to achieve smooth extubation in a dose-dependent manner. Intravenous dexmedetomidine 1 μg∙kg and 2 μg∙kg pre-medication decreased MAC by 41% and 64%, respectively. Chinese Clinical Trial Registry (ChiCTR): ChiCTR-IOD-17011601 , date of registration: 09 Jun 2017, retrospectively registered.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>29343232</pmid><doi>10.1186/s12871-018-0469-9</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9569-2454</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2253
ispartof BMC anesthesiology, 2018-01, Vol.18 (1), p.9-9, Article 9
issn 1471-2253
1471-2253
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7d16b398f957435dbc60dab8ab2875ea
source Open Access: PubMed Central; ProQuest - Publicly Available Content Database
subjects Dexmedetomidine
Dosage and administration
Extubation
Intubation
Methods
Minimum alveolar concentration
Pediatric
Pediatric anesthesia
Sevoflurane
title Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A52%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20dexmedetomidine%20pre-medication%20reduces%20the%20required%20minimum%20alveolar%20concentration%20of%20sevoflurane%20for%20smooth%20tracheal%20extubation%20in%20anesthetized%20children:%20a%20randomized%20clinical%20trial&rft.jtitle=BMC%20anesthesiology&rft.au=Di,%20Meiqin&rft.date=2018-01-17&rft.volume=18&rft.issue=1&rft.spage=9&rft.epage=9&rft.pages=9-9&rft.artnum=9&rft.issn=1471-2253&rft.eissn=1471-2253&rft_id=info:doi/10.1186/s12871-018-0469-9&rft_dat=%3Cgale_doaj_%3EA523594097%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c532t-66bd981b8e7c9cd0a4a703c545f2352656c9e509300ab772e7f43aa42ca0d9d63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1989595901&rft_id=info:pmid/29343232&rft_galeid=A523594097&rfr_iscdi=true